| Wound repair at a glance TJ Shaw, P Martin Journal of cell science 122 (18), 3209-3213, 2009 | 1021 | 2009 |
| Spatial and single-cell transcriptional profiling identifies functionally distinct human dermal fibroblast subpopulations C Philippeos, SB Telerman, B Oulès, AO Pisco, TJ Shaw, R Elgueta, ... Journal of Investigative Dermatology 138 (4), 811-825, 2018 | 434 | 2018 |
| Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring R Mori, TJ Shaw, P Martin The Journal of experimental medicine 205 (1), 43-51, 2008 | 366 | 2008 |
| Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer TJ Shaw, MK Senterman, K Dawson, CA Crane, BC Vanderhyden Molecular therapy 10 (6), 1032-1042, 2004 | 331 | 2004 |
| Wound repair: a showcase for cell plasticity and migration TJ Shaw, P Martin Current opinion in cell biology 42, 29-37, 2016 | 250 | 2016 |
| Epigenetic reprogramming during wound healing: loss of polycomb‐mediated silencing may enable upregulation of repair genes T Shaw, P Martin EMBO reports 10 (8), 881-886, 2009 | 201 | 2009 |
| Animal models of ovarian cancer BC Vanderhyden, TJ Shaw, JF Ethier Reproductive Biology and Endocrinology 1, 1-11, 2003 | 186 | 2003 |
| Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study RJ Schilder, MW Sill, RB Lee, TJ Shaw, MK Senterman, AJ Klein-Szanto, ... Journal of clinical oncology 26 (20), 3418-3425, 2008 | 138 | 2008 |
| Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells MD Steller, TJ Shaw, BC Vanderhyden, JF Ethier Molecular cancer research 3 (1), 50-61, 2005 | 94 | 2005 |
| Models of ovarian cancer—are we there yet? K Garson, TJ Shaw, KV Clark, DS Yao, BC Vanderhyden Molecular and cellular endocrinology 239 (1-2), 15-26, 2005 | 89 | 2005 |
| Dissecting fibroblast heterogeneity in health and fibrotic disease TJ Shaw, E Rognoni Current rheumatology reports 22, 1-10, 2020 | 83 | 2020 |
| Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo TJ Shaw, EC Lacasse, JP Durkin, BC Vanderhyden International journal of cancer 122 (6), 1430-1434, 2008 | 71 | 2008 |
| Gene induction following wounding of wild‐type versus macrophage‐deficient Drosophila embryos B Stramer, M Winfield, T Shaw, TH Millard, S Woolner, P Martin EMBO reports 9 (5), 465-471, 2008 | 62 | 2008 |
| Cyclic AMP in ovarian cancer cells both inhibits proliferation and increases c-KIT expression TJ Shaw, EJ Keszthelyi, AM Tonary, M Cada, BC Vanderhyden Experimental cell research 273 (1), 95-106, 2002 | 51 | 2002 |
| Histone deacetylase 2 is upregulated in normal and keloid scars EJF O'connor, II Badshah, LY Addae, P Kundasamy, S Thanabalasingam, ... The Journal of investigative dermatology 132 (4), 1293, 2012 | 44 | 2012 |
| Metabolic perturbations in fibrosis disease CY Ung, A Onoufriadis, M Parsons, JA McGrath, TJ Shaw The International Journal of Biochemistry & Cell Biology 139, 106073, 2021 | 41 | 2021 |
| AKT mediates the pro-survival effects of KIT in ovarian cancer cells and is a determinant of sensitivity to imatinib mesylate TJ Shaw, BC Vanderhyden Gynecologic oncology 105 (1), 122-131, 2007 | 38 | 2007 |
| A workflow for rapid unbiased quantification of fibrillar feature alignment in biological images S Marcotti, D Belo de Freitas, LD Troughton, FN Kenny, TJ Shaw, ... Frontiers in computer science 3, 745831, 2021 | 34 | 2021 |
| Comorbidities of keloid and hypertrophic scars among participants in UK Biobank CY Ung, A Warwick, A Onoufriadis, JN Barker, M Parsons, JA McGrath, ... JAMA dermatology 159 (2), 172-181, 2023 | 33 | 2023 |
| The biomechanical and histological sequelae of common skin banking methods JMB Wood, M Soldin, TJ Shaw, M Szarko Journal of Biomechanics 47 (5), 1215-1219, 2014 | 33 | 2014 |
